Cutler Group LP Harrow Health, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$8.5 - $12.0 $11,900 - $16,800	-1,400 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$6.26 - $11.03 $10,642 - $18,751	-1,700 Reduced 54.84%	1,400 $9,000
Q4 2020 Jan 21, 2021	BUY	$4.76 - $6.93 $9,520 - $13,860	2,000 Added 181.82%	3,100 $21,000
Q3 2020 Oct 27, 2020	SELL	$4.71 - $7.36 $2,826 - $4,416	-600 Reduced 35.29%	1,100 $6,000
Q2 2020 Jul 22, 2020	BUY	$3.61 - $6.47 $1,805 - $3,235	500 Added 41.67%	1,700 $8,000
Q1 2020 May 07, 2020	SELL	$3.5 - $7.31 $19,250 - $40,205	-5,500 Reduced 82.09%	1,200 $4,000
Q4 2019 Feb 06, 2020	BUY	$4.6 - $7.88 $5,979 - $10,244	1,300 Added 24.07%	6,700 $52,000
Q3 2019 Oct 28, 2019	BUY	$4.89 - $8.0 $23,472 - $38,400	4,800 Added 800.0%	5,400 $30,000
Q2 2019 Aug 09, 2019	BUY	$4.2 - $8.7 $2,520 - $5,220	600 New	600 $5,000

185

21.1M

679K

1.27M

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $631M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.